Carecubes, Inc.

Carecubes, Inc. manufactures the Carecube, an FDA 510(k)-cleared portable isolation unit designed for rapid deployment in healthcare settings to contain airborne infectious disease transmission. The Carecube converts a standard hospital bed into an isolation bed in approximately 10 minutes, exceeding CDC standards for Airborne Infection Isolation Rooms. The system isolates the pathogen rather than the patient, enabling bedside care while protecting healthcare staff and other patients. Key operational benefits include minimized PPE usage and donning/doffing time, freed-up negative pressure rooms, reduced staffing costs, and improved patient throughput. The product was initially developed with funding from the Defense Advanced Research Projects Agency (DARPA) and further supported by the Centers for Disease Control and Prevention (CDC) and the Administration for Strategic Preparedness and Response (ASPR). Development occurred in collaboration with frontline clinical teams across diverse U.S. hospital settings and in partnership with the University of Nebraska Medical Center, a recognized leader in infectious disease response. The Carecube addresses infectious disease response for known pathogens including measles, RSV, and TB, as well as emerging infectious threats. Target markets include rural healthcare facilities, major health systems, and international healthcare providers. The company positions the Carecube as a scalable, affordable solution that allows high-quality, compassionate care delivery without compromising infection control or staff safety.